-+ 0.00%
-+ 0.00%
-+ 0.00%

Synbio International signs exclusive nutraceutical licensing deal with MD PHD Wellness for US, Canada rights

PUBT·09/08/2026 12:06:24
Listen to the news
Synbio International signs exclusive nutraceutical licensing deal with MD PHD Wellness for US, Canada rights
  • Synbio International entered an exclusive licensing, manufacturing, supply, and revenue-sharing agreement with MD PHD Wellness for the US and Canada.
  • Deal grants rights to commercialize MD PHD’s proprietary nutraceutical formulations, led by an anti-anxiety product marketed under the Healing Force brand.
  • MD PHD will run development, manufacturing, quality assurance, and supply chain; Synbio will handle branding, marketing, sales, and distribution.
  • Profits will be shared once approved manufacturing and commercialization costs are recovered.
  • Partnership is positioned to accelerate near-term revenue while supporting a broader strategy that includes AI-driven mental health technologies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Synbio International Inc. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202609080800TNWSWRCACNPR_____1kWVF2m2K) on September 08, 2026, and is solely responsible for the information contained therein.